Nucor reports Q4 results on November 5, riding a 16% share price gain over the past month to $273.87, with Wall Street's price targets still playing catch-up to a stock that has outpaced most of its peers. The analyst revision wave is the defining feature of the setup. JP Morgan raised its target to $304 on October 28, maintaining Overweight. Barclays went further, lifting to $320…
NUE downgraded to Hold by Freedom Broker; PT cut to $285 from $305, implying 7.5% downside from $265.14 close.
Key data as of 4 Nov 2026
Nucor reports Q4 results on November 5, riding a 16% share price gain over the past month to $273.87, with Wall Street's price targets still playing catch-up to a stock that has outpaced most of its peers. The analyst…
Nucor delivered a strong Q3 result last week, and the stock has responded with its best two-day run in months, leaving analysts scrambling to update numbers that now look too conservative. The stock closed Tuesday at…
NUE reports Q3 results on Monday, October 26, with the most notable pre-earnings signal coming not from shorts but from the analyst community, where Barclays lifted its target to $306 four days ago, the highest on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NUE — free to start on ORTEX.
Sign up for free →Open NUE on ORTEX